Synageva BioPharma (GEVA) Announces $60 Million Common Stock Offering

Synageva BioPharma Corp. (NASDAQ: GEVA) today announced that it has commenced a $60 million underwritten public offering of shares of its common stock. In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase additional shares of common stock to cover over-allotments, if any, equal to up to 15% of the number of shares of common stock sold in the offering. Morgan Stanley and J.P. Morgan are acting as joint book-running managers in the offering, and Cowen and Company, Leerink Swann and Wedbush PacGrow Life Sciences are acting as co-managers in the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Baiya International Group (BIYA) files $200M mixed shelf
• Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders